JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES

Abstract

Cancer affects almost 18 million around the world in 2018, and the most common cancer is the lung cancer. COVID-19 is an acute respiratory disease caused by novel coronavirus SARS-CoV-2 or 2019-nCoV was first reported in Wuhan, China in December 2019. Recently, on March 11, 2020, COVID-19 was declared by the World Health Organization (WHO) as a virus pandemic disease. Furthermore, it has been known that the malig-nancy and anticancer treatments, such as chemotherapy or surgery cause systemic immunosuppressive state in patients with cancer that is why cancer patients are more vulnerable to infection than others and for especially for COVID-19 and with a high probability of complications. Additionally, the major concern for patients with cancer is the incapacity to get fundamental medical services due to the pandemic spread. In Morocco, the pre-vention of contamination, the prioritization of care and the organization of the price in therapeutic charge of patients by the various oncology centers and services were applied which leads that most of patients with can-cer continue their treatment even if we are in the COVID-19 pandemic.

Keywords: COVID-19- Cancer- Pandemic-Morocco